Valuation: FDC Limited

Market Cap 52.29B 550M 477M 445M 409M 773M 782M 5.25B 2.05B 26.14B 2.06B 2.02B 86.62B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 496M 430M 401M 369M 697M 705M 4.73B 1.85B 23.57B 1.86B 1.82B 78.09B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.01%
1 week-3.43%
Current month-1.73%
1 month-6.98%
3 months+10.50%
6 months+5.55%
Current year-4.80%
1 week 400
Extreme 400
425
1 month 397.55
Extreme 397.55
442
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
528.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 18/11/2009
Chief Executive Officer 63 30/09/1993
Director of Finance/CFO - 23/10/2025
Director TitleAgeSince
Director/Board Member 48 31/12/2001
Director/Board Member 63 30/09/1993
Chairman 90 31/03/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.01%-3.43%-15.36%+7.81% 688M
-0.51%-6.83%+46.35%+148.39% 1T
+0.20%-4.14%+52.35%+49.40% 613B
-0.53%-5.10%+24.88%+63.57% 433B
+0.48%-0.67%+39.13%+34.00% 350B
+0.08%-3.05%+32.29%+39.91% 292B
+2.09%-8.91%+5.73%+7.71% 239B
+1.75%-5.79%-0.39%-42.69% 206B
+2.94%+3.66%+31.37%+69.06% 204B
+3.13%+3.64%+19.52%+79.09% 163B
Average +1.21%-3.70%+23.59%+45.62% 350.12B
Weighted average by Cap. +0.81%-4.28%+35.19%+71.35%

Financials

2024 2025
Net sales 19.43B 204M 177M 165M 152M 287M 290M 1.95B 762M 9.71B 767M 750M 32.18B 21.08B 222M 192M 179M 165M 312M 315M 2.12B 827M 10.54B 832M 814M 34.92B
Net income 3.05B 32.09M 27.86M 25.98M 23.86M 45.13M 45.63M 306M 120M 1.53B 120M 118M 5.06B 2.67B 28.05M 24.35M 22.71M 20.86M 39.45M 39.88M 268M 105M 1.33B 105M 103M 4.42B
Net Debt -4.55B -47.83M -41.53M -38.72M -35.57M -67.27M -68.01M -456M -178M -2.27B -180M -176M -7.54B -5.15B -54.14M -47.01M -43.83M -40.26M -76.15M -76.98M -517M -202M -2.57B -203M -199M -8.53B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
04/08/26 403.00 -0.01% 3,591
03/08/26 ₹403.05 -1.72% 28,286
31/07/26 ₹410.10 +0.98% 2,555
30/07/26 ₹406.10 -1.98% 27,341
29/07/26 ₹414.30 +1.61% 5,795
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B